Tl-201 uptake in brown tumors of hyperparathyroidism

Clin Nucl Med. 1991 Dec;16(12):931-5. doi: 10.1097/00003072-199112000-00012.

Abstract

Tl-201 chloride bone scans were performed on nine patients with primary hyperparathyroidism just after Tl-201 and Tc-99m parathyroid subtraction scintigraphy. Bone lesions accumulate Tl-201, especially in sites of brown tumor formation. This was proven by the histopathologic examination of two patients. Eight patients had bone scans with Tc-99m MDP. The lesion-to-background ratio was quantified in seven patients for Tl-201 and in four patients for Tc-99m MDP. Tl-201 uptake of the lesions were quantified in two patients. The lesion-to-background ratio was 1.63 +/- 0.21 and 2.51 +/- 0.88 for Tl-201 and Tc-99m MDP, respectively. A Ga-67 citrate scan was performed on one patient, and the lesion-to-background ratio was 1.49 +/- 0.06. The accumulation of Tl-201 in brown tumors of bone might be due to increased blood flow and local metabolic activity. Tl-201 chloride was inferior to Tc-99m MDP in lesion detection. It is concluded that bone imaging with Tl-201 can easily be performed following parathyroid subtraction scintigraphy to delineate the sites of brown tumor formation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Hyperparathyroidism / complications*
  • Hyperparathyroidism / diagnostic imaging
  • Male
  • Middle Aged
  • Osteitis Fibrosa Cystica / diagnostic imaging*
  • Osteitis Fibrosa Cystica / etiology
  • Osteitis Fibrosa Cystica / metabolism
  • Radionuclide Imaging
  • Technetium Tc 99m Medronate
  • Thallium Radioisotopes* / pharmacokinetics

Substances

  • Thallium Radioisotopes
  • Technetium Tc 99m Medronate